ALLO Allogene Therapeutics, Inc. - Common Stock
$2,13
Prix · Aoû 19, 2026
Données fondamentales au Aoû 12, 2026
Fourchette 52 semaines
$1–$4
32% of range
Note des analystes
BUY
18 analysts
Objectif de cours
$9
+324% upside
P/E (TTM)
-2.6
ROE
-59.9%
Marge nette
—
ALLO Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$2.12
Capitalisation Boursière
$520M
P/E (TTM)
-2.6
BPA (TTM)
$-0.87
Revenus (TTM)
$0
Rendement div.
—
ROE
-59.9%
Dette/Capitaux propres
—
Fourchette 52 semaines
$1 – $4
ALLO Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$0
2022-12-31
→
2025-12-31
BPA
$-0.87
2022-12-31
→
2025-12-31
Flux de trésorerie libre
$-150M
2023-12-31
→
2025-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
ALLO
Médiane des pairs
P/E (TTM)
-2.6
19.6
P/B
1.8
2.6
Price / FCF (Cours / FCF)
-3.5
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
ALLO
Médiane des pairs
ROA
-39.6%
-40.3%
ROE
-59.9%
-42.4%
ROIC
-71.5%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
ALLO
Médiane des pairs
Current Ratio (Ratio de liquidité)
7.9
5.4
Quick Ratio (Ratio de liquidité réduite)
1.6
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
ALLO
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-76.8%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
-94.2%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
ALLO
Médiane des pairs
ALLO Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
18 analystes
- Achat fort 6 33,3%
- Achat 10 55,6%
- Conserver 2 11,1%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
9 analystes · 2026-08-15
Médiane
$9.00
← En dessous de tous les objectifs
$2.12
Bas
$4.00
Haut
$14.00
Objectif médian
$9.00
+323,5%
Objectif moyen
$9.00
+323,5%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.04%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.13 | $-0.17 | 0.04% |
| 31 mars 2026 | $-0.18 | $-0.19 | 0.01% |
| 31 décembre 2025 | $-0.17 | $-0.22 | 0.05% |
| 30 septembre 2025 | $-0.19 | $-0.23 | 0.04% |
| 30 juin 2025 | $-0.23 | $-0.28 | 0.05% |
| 31 mars 2025 | $-0.28 | $-0.30 | 0.02% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| EIKN | — | — | — | — | — | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22.0K | $95.0K | $156.0K | $114M | $0 | $0 | |
| R&D Expense | $150M | $192M | $243M | $256M | $220M | $193M | $145M | |
| SG&A Expense | $57M | $65M | $72M | $79M | $74M | $65M | $57M | |
| Operating Expenses | $209M | $273M | $328M | $336M | $294M | $258M | $202M | |
| Operating Income | $-209M | $-273M | $-328M | $-336M | $-180M | $-258M | $-202M | |
| Interest Expense | · | · | · | · | · | $0 | $0 | |
| Other Non-op | $215.0K | $-4M | $-18M | $-9M | $-4M | $-67M | $17M | |
| Pretax Income | $-191M | $-257M | $-327M | · | $-257M | $-250M | $-185M | |
| Income Tax | $0 | $443.0K | $0 | $0 | $0 | $0 | $-331.0K | |
| Net Income | $-191M | $-258M | $-327M | $-340M | $-182M | $-316M | $-185M | |
| EPS (Basic) | $-0.87 | $-1.32 | $-2.09 | $-2.38 | $-1.34 | $-2.63 | $-1.83 | |
| EPS (Diluted) | $-0.87 | $-1.32 | $-2.09 | $-2.38 | $-1.34 | $-2.63 | $-1.83 | |
| Shares (Basic) | 220,622,669 | 194,811,756 | 156,931,778 | 143,147,165 | 135,820,386 | 120,370,177 | 101,061,149 | |
| Shares (Diluted) | 220,622,669 | 194,811,756 | 156,931,778 | 143,147,165 | 135,820,386 | 120,370,177 | 101,061,149 | |
| EBITDA | $-197M | $-260M | $-314M | · | $-245M | $-251M | $-197M |
Bilan 21
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $52M | $75M | $83M | $62M | $173M | $183M | $175M | |
| Short-term Investments | · | · | · | · | $284M | $645M | $355M | |
| Prepaid Expense | $8M | $11M | $10M | $12M | $14M | $17M | $14M | |
| Current Assets | $258M | $303M | $459M | $529M | $471M | $845M | $545M | |
| PP&E (Net) | $73M | $86M | $99M | $113M | $123M | $119M | $56M | |
| PP&E (Gross) | $145M | $149M | $151M | $150M | $146M | $132M | $62M | |
| Accum. Depreciation | $73M | $63M | $51M | $37M | $23M | $13M | $5M | |
| Intangibles | · | · | · | · | · | $0 | $151.0K | |
| Other Non-current Assets | $4M | $2M | $7M | $10M | $6M | $5M | $5M | |
| Total Assets | $416M | $549M | $643M | $822M | $1.05B | $1.23B | $718M | |
| Accounts Payable | $4M | $5M | $6M | $14M | $10M | $10M | $9M | |
| Current Liabilities | $33M | $36M | $37M | $54M | $48M | $94M | $33M | |
| Capital Leases | $75M | $83M | $88M | $95M | $70M | $51M | $51M | |
| Other Non-current Liabilities | $16M | $8M | $5M | $6M | $8M | $3M | $4M | |
| Total Liabilities | $123M | $127M | $131M | $155M | $126M | $148M | $89M | |
| Common Stock | $229.0K | $212.0K | $169.0K | $144.0K | $142.0K | $140.0K | $124.0K | |
| Retained Earnings | $-2.01B | $-1.82B | $-1.56B | $-1.23B | $-895M | $-713M | $-396M | |
| AOCI | $269.0K | $-89.0K | $-955.0K | $-10M | $-3M | $268.0K | $1M | |
| Stockholders' Equity | $293M | $422M | $512M | $667M | $925M | $1.01B | $629M | |
| Liabilities + Equity | $416M | $549M | $643M | $822M | $1.05B | $1.23B | $718M | |
| Shares Outstanding | 229,413,523 | 212,210,597 | 168,642,238 | 144,438,304 | 142,623,065 | 140,474,305 | 124,267,358 |
Flux de trésorerie 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $14M | $14M | $14M | $10M | $7M | $5M | |
| Stock-based Comp | $38M | $52M | $66M | $84M | $81M | $65M | $46M | |
| Deferred Tax | $0 | $443.0K | $0 | · | · | · | · | |
| Amort. of Intangibles | · | · | · | $0 | $0 | $151.0K | $603.0K | |
| Restructuring | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-8M | $-9M | $9M | · | $-19M | $62M | $-3M | |
| Operating Cash Flow | $-149M | $-200M | $-238M | $-221M | $-185M | $-115M | $-137M | |
| CapEx | $386.0K | $694.0K | $2M | $5M | $21M | $66M | $51M | |
| Investing Cash Flow | $96M | $76M | $163M | $106M | $164M | $-505M | $164M | |
| Stock Issued | · | · | $91M | $0 | $0 | $596M | $0 | |
| Net Stock Activity | · | · | $91M | · | $0 | $622M | $54M | |
| Financing Cash Flow | $30M | $117M | $96M | $3M | $12M | $634M | $59M | |
| Net Change in Cash | $-24M | $-8M | $21M | $-111M | $-9M | $13M | $86M | |
| Free Cash Flow | $-150M | $-201M | $-239M | · | $-206M | $-181M | $-188M | |
| Levered FCF | · | · | · | · | · | $-181M | $-188M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1241813.6% | -344986.3% | · | -664.6% | · | · | |
| Net Margin | · | -1170863.6% | -344489.5% | · | -667.7% | · | · | |
| Pretax Margin | · | -1168850.0% | · | · | -667.7% | · | · | |
| EBITDA Margin | · | -1179818.2% | -330039.0% | · | -637.3% | · | · | |
| ROA | -39.6% | -43.2% | -48.3% | · | -22.7% | -25.7% | -24.8% | |
| ROE | -59.9% | -58.1% | -59.9% | · | -27.3% | -22.8% | -29.6% | |
| ROIC | -71.5% | -64.8% | · | · | -27.9% | -23.9% | -32.1% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 8.5 | 12.4 | · | 9.8 | 9.0 | 16.5 | |
| Quick Ratio | 1.6 | 2.1 | 2.2 | · | 9.5 | 8.8 | 16.0 |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · |
Taux de croissance 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -76.8% | -39.1% | -99.9% | · | · | · | |
| Revenue CAGR 3Y | · | -94.2% | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $22.0K | $95.0K | $156.0K | $114M | $0 | $0 | |
| Net Income TTM | $-191M | $-258M | $-327M | $-340M | $-182M | $-316M | $-185M | |
| Market Cap | $314M | $452M | $541M | · | $2.13B | $3.55B | $3.23B | |
| P/E | -1.6 | -1.6 | -1.5 | -2.6 | -11.1 | -9.6 | -14.2 | |
| P/S | · | 20545.8 | 5698.3 | · | 18.7 | · | · | |
| P/B | 1.1 | 1.1 | 1.1 | · | 2.3 | 3.3 | 5.1 | |
| P / Tangible Book | 1.1 | 1.1 | 1.1 | 1.4 | 2.3 | 3.5 | · | |
| P / Cash Flow | -2.1 | -2.3 | -2.3 | · | -11.5 | -30.8 | -23.5 | |
| P / FCF | -2.1 | -2.2 | -2.3 | · | -10.3 | -19.6 | -17.2 | |
| Earnings Yield | -63.5% | -62.0% | -65.1% | -37.8% | -9.0% | -10.4% | -7.0% |
Compte de résultat 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $22.0K | $21.0K | $22.0K | $22.0K | $30.0K | $-40.0K | $27.0K | |
| R&D Expense | $31M | $32M | $29M | $31M | $40M | $50M | $45M | $45M | $50M | $52M | $55M | $46M | $62M | $80M | $75M | $64M | |
| SG&A Expense | $21M | $14M | $14M | $14M | $14M | $15M | $16M | $16M | $16M | $17M | $17M | $17M | $19M | $19M | $21M | $19M | |
| Operating Expenses | $52M | $46M | $42M | $45M | $57M | $65M | $60M | $72M | $71M | $70M | $85M | $63M | $81M | $99M | $96M | $83M | |
| Operating Income | $-47M | $-46M | $-42M | $-45M | $-57M | $-65M | $-60M | $-72M | $-71M | $-70M | $-85M | $-63M | $-81M | $-99M | $-96M | $-83M | |
| Other Non-op | $-61.0K | $212.0K | $247.0K | $-81.0K | $-43.0K | $92.0K | $-2M | $-1M | $85.0K | $-929.0K | $-12M | $-5M | $-2M | $2M | $-10M | $-3M | |
| Net Income | $-43M | $-43M | $-39M | $-41M | $-51M | $-60M | $-60M | $-66M | $-66M | $-65M | $-86M | $-62M | $-79M | $-100M | $-103M | $-84M | |
| EPS (Basic) | $-0.13 | $-0.18 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.27 | $-0.32 | $-0.35 | $-0.38 | $-0.49 | $-0.37 | $-0.54 | $-0.69 | $-0.72 | $-0.59 | |
| EPS (Diluted) | $-0.13 | $-0.18 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.27 | $-0.32 | $-0.35 | $-0.38 | $-0.49 | $-0.37 | $-0.54 | $-0.69 | $-0.72 | $-0.59 | |
| Shares (Basic) | 328,930,269 | 240,290,782 | -435,704,178 | 222,038,680 | 218,929,548 | 215,358,619 | -373,531,795 | 209,188,551 | 190,026,638 | 169,128,362 | -302,076,887 | 167,649,010 | 146,795,826 | 144,563,829 | -285,255,907 | 143,661,721 | |
| Shares (Diluted) | 328,930,269 | 240,290,782 | -435,704,178 | 222,038,680 | 218,929,548 | 215,358,619 | -373,531,795 | 209,188,551 | 190,026,638 | 169,128,362 | -302,076,887 | 167,649,010 | 146,795,826 | 144,563,829 | -285,255,907 | 143,661,721 | |
| EBITDA | $-47M | $-43M | · | $-45M | $-57M | $-62M | · | $-72M | $-71M | $-70M | · | $-63M | $-81M | $-99M | · | $-82M |
Bilan 19
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $39M | $30M | $52M | $38M | $52M | $42M | $75M | $51M | $171M | $51M | $83M | $69M | $155M | $110M | $62M | $74M | |
| Prepaid Expense | $7M | $6M | $8M | $9M | $10M | $12M | $11M | $13M | $12M | $11M | $10M | $8M | $10M | $10M | $12M | $17M | |
| Current Assets | $340M | $273M | $258M | $261M | $283M | $292M | $303M | $304M | $457M | $395M | $459M | $473M | $502M | $481M | $529M | $569M | |
| PP&E (Net) | $67M | $70M | $73M | $76M | $79M | $83M | $86M | $89M | $92M | $96M | $99M | $103M | $106M | $110M | $113M | $114M | |
| PP&E (Gross) | $145M | $145M | $145M | $145M | $146M | $149M | $149M | $149M | $148M | $151M | $151M | $150M | $150M | $150M | $150M | $149M | |
| Accum. Depreciation | $78M | $75M | $73M | $70M | $67M | $66M | $63M | $60M | $56M | $55M | $51M | $48M | $44M | $40M | $37M | $35M | |
| Other Non-current Assets | $4M | $4M | $4M | $4M | $4M | $2M | $2M | $5M | $6M | $5M | $7M | $10M | $9M | $9M | $10M | $9M | |
| Total Assets | $550M | $396M | $416M | $440M | $471M | $508M | $549M | $589M | $647M | $586M | $643M | $712M | $771M | $747M | $822M | $888M | |
| Accounts Payable | $6M | $5M | $4M | $4M | $5M | $5M | $5M | $6M | $13M | $6M | $6M | $6M | $10M | $15M | $14M | $11M | |
| Current Liabilities | $32M | $28M | $33M | $32M | $32M | $30M | $36M | $33M | $37M | $31M | $37M | $38M | $55M | $60M | $54M | $49M | |
| Capital Leases | $70M | $73M | $75M | $77M | $79M | $81M | $83M | $85M | $87M | $89M | $88M | $90M | $92M | $94M | $95M | $97M | |
| Other Non-current Liabilities | $12M | $16M | $16M | $15M | $15M | $11M | $8M | $8M | $8M | $5M | $5M | $1M | $2M | $2M | $6M | $2M | |
| Total Liabilities | $114M | $117M | $123M | $124M | $126M | $123M | $127M | $125M | $132M | $125M | $131M | $129M | $148M | $155M | $155M | $148M | |
| Common Stock | $345.0K | $245.0K | $229.0K | $223.0K | $220.0K | $219.0K | $212.0K | $210.0K | $209.0K | $170.0K | $169.0K | $168.0K | $167.0K | $146.0K | $144.0K | $144.0K | |
| Retained Earnings | $-2.10B | $-2.05B | $-2.01B | $-1.97B | $-1.93B | $-1.88B | $-1.82B | $-1.76B | $-1.69B | $-1.63B | $-1.56B | $-1.47B | $-1.41B | $-1.33B | $-1.23B | $-1.14B | |
| AOCI | $-518.0K | $-183.0K | $269.0K | $235.0K | $-45.0K | $43.0K | $-89.0K | $157.0K | $-780.0K | $-927.0K | $-955.0K | $-2M | $-4M | $-6M | $-10M | $-13M | |
| Stockholders' Equity | $436M | $279M | $293M | $315M | $345M | $385M | $422M | $464M | $515M | $461M | $512M | $583M | $623M | $592M | $667M | $740M | |
| Liabilities + Equity | $550M | $396M | $416M | $440M | $471M | $508M | $549M | $589M | $647M | $586M | $643M | $712M | $771M | $747M | $822M | $888M | |
| Shares Outstanding | 345,345,427 | 244,816,413 | 229,413,523 | 223,163,672 | 220,133,876 | 218,598,262 | 212,210,597 | 209,500,137 | 209,049,485 | 170,452,967 | 168,642,238 | 168,175,221 | 167,133,664 | 145,740,333 | 144,438,304 | 144,031,588 |
Flux de trésorerie 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $4M | · | · | · | · | |
| Stock-based Comp | $12M | $8M | $8M | $9M | $9M | $12M | $13M | $13M | $14M | $12M | $15M | $15M | $17M | $19M | $17M | $21M | |
| Restructuring | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $19M | · | · | · | $-8M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $-13M | $-28M | $-30M | $-39M | $-53M | $-37M | $-44M | $-64M | $-56M | $-54M | $-56M | $-62M | $-67M | $-62M | $-48M | |
| CapEx | $150.0K | $9.0K | $0 | $243.0K | $44.0K | $99.0K | $257.0K | $429.0K | $0 | $8.0K | $181.0K | $12.0K | $288.0K | $1M | $2M | $223.0K | |
| Investing Cash Flow | $-148M | $-30M | $34M | $12M | $44M | $6M | $55M | $-76M | $75M | $22M | $67M | $-34M | $17M | $113M | $50M | $25M | |
| Stock Issued | · | · | · | · | · | $10M | · | · | · | $0 | · | $3M | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $10M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $188M | $21M | $8M | $3M | $5M | $14M | $6M | $679.0K | $109M | $2M | $155.0K | $4M | $90M | $2M | $46.0K | $1M | |
| Net Change in Cash | $8M | $-21M | $14M | $-15M | $10M | $-33M | $24M | $-119M | $120M | $-32M | $14M | $-86M | $45M | $48M | $-12M | $-22M | |
| Free Cash Flow | · | $-13M | · | · | · | $-53M | · | · | · | $-56M | · | · | · | $-68M | · | · |
Rentabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1011.2% | · | · | · | · | · | · | · | · | -315927.3% | · | -146453.5% | -182995.5% | -190519.2% | · | -168344.9% | |
| Net Margin | -919.8% | · | · | · | · | · | · | · | · | -295454.6% | · | -142593.0% | -177247.7% | -189815.4% | · | -169689.8% | |
| EBITDA Margin | -1011.2% | · | · | · | · | · | · | · | · | -315927.3% | · | -146453.5% | -182995.5% | -190519.2% | · | -168344.9% | |
| ROA | -8.4% | -9.4% | · | -8.1% | -9.1% | -10.9% | · | -10.2% | -9.4% | -9.8% | · | -7.7% | -9.1% | -11.5% | · | -8.5% | |
| ROE | -10.9% | -12.8% | · | -10.6% | -11.8% | -14.1% | · | -12.7% | -11.7% | -12.3% | · | -9.3% | -10.9% | -13.6% | · | -9.7% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.7 | 9.6 | · | 8.2 | 8.9 | 9.7 | · | 9.3 | 12.3 | 12.8 | · | 12.6 | 9.2 | 8.1 | · | 11.6 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.2 | 1.7 | 1.4 | · | 1.6 | 4.6 | 1.7 | · | 1.8 | 2.8 | 1.8 | · | 1.5 |
Efficacité 1
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | · | $0 | $0 | $22.0K | · | $44.0K | $66.0K | $96.0K | · | $101.0K | $143.0K | $160.0K | · | $179.0K | |
| Net Income TTM | $-178M | $-195M | · | $-218M | $-243M | $-257M | · | $-260M | $-273M | $-306M | · | $-326M | $-344M | $-343M | · | $-321M | |
| Market Cap | $718M | $597M | · | $277M | $249M | $319M | · | $587M | $487M | $762M | · | $533M | $831M | $720M | · | $1.56B | |
| P/E | -2.8 | -2.8 | · | -1.2 | -1.0 | -1.1 | · | -2.0 | -1.4 | -2.3 | · | -1.4 | -2.1 | -2.1 | · | -4.7 | |
| P/S | · | · | · | · | · | 14507.0 | · | 13331.8 | 7380.1 | 7936.7 | · | 5278.4 | 5808.8 | 4499.7 | · | 8690.2 | |
| P/B | 1.6 | 2.1 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | 0.9 | 1.7 | · | 0.9 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 1.6 | 2.1 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | 0.9 | 1.7 | · | 0.9 | 1.3 | 1.2 | · | 2.1 | |
| P / Cash Flow | · | -46.3 | · | · | · | -6.0 | · | · | · | -13.6 | · | · | · | -10.8 | · | · | |
| P / FCF | · | -46.2 | · | · | · | -6.0 | · | · | · | -13.6 | · | · | · | -10.6 | · | · | |
| Earnings Yield | -35.1% | -36.1% | · | -82.3% | -104.4% | -91.1% | · | -50.7% | -70.4% | -44.3% | · | -69.1% | -47.9% | -48.6% | · | -21.1% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Revenu | $0 | $22.0K | $95.0K | — | — |
| Marge d'exploitation % | — | -1241813.6% | -344986.3% | — | — |
| Résultat net | $-191M | $-258M | $-327M | — | — |
| BPA dilué | $-0.87 | $-1.32 | $-2.09 | — | — |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 7.9 | 8.5 | 12.4 | — | — |
| Ratio de liquidité réduite | 1.6 | 2.1 | 2.2 | — | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-150M | $-201M | $-239M | — | — |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 231 déclarants · $530.0M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 37 (-10 vs T. préc.) | 24 (+13 vs T. préc.) | 90 (+13 vs T. préc.) | 55 (+12 vs T. préc.) | +123.4M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Pfizer Inc | $46 928 245 | 22 032 040 | 8,85% | Actions |
| Frazier Life Sciences Management, L.P. | $46 689 069 | 22 446 668 | 8,81% | Actions |
| STATE STREET CORP | $39 573 718 | 19 025 826 | 7,47% | Actions |
| TPG GP A, LLC | $38 929 916 | 18 716 306 | 7,34% | Actions |
| Sio Capital Management, LLC | $27 712 736 | 13 323 431 | 5,23% | Actions |
| PRIMECAP MANAGEMENT CO/CA/ | $27 296 756 | 13 123 440 | 5,15% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $25 306 603 | 12 166 636 | 4,77% | Actions |
| FMR LLC | $24 957 776 | 11 998 931 | 4,71% | Actions |
| CITADEL ADVISORS LLC | $19 676 871 | 9 460 034 | 3,71% | Actions |
| TWO SIGMA INVESTMENTS, LP | $16 191 444 | 7 784 348 | 3,05% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $12 494 150 | 6 005 150 | 2,36% | Actions |
| GOLDMAN SACHS GROUP INC | $12 467 422 | 5 993 953 | 2,35% | Actions |
| VANGUARD GROUP INC | $11 178 392 | 8 159 410 | 2,11% | Actions |
| GordonMD Global Investments LP | $11 019 840 | 5 298 000 | 2,08% | Actions |
| Patient Square Capital LP | $10 504 000 | 5 050 000 | 1,98% | Actions |
| Aberdeen Group plc | $10 403 644 | 5 001 752 | 1,96% | Actions |
| MILLENNIUM MANAGEMENT LLC | $10 075 289 | 4 843 889 | 1,90% | Actions |
| Woodline Partners LP | $9 361 298 | 4 500 624 | 1,77% | Actions |
| Candriam S.C.A. | $9 010 818 | 4 336 296 | 1,70% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 761 122 | 4 212 078 | 1,65% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $7 975 369 | 3 834 312 | 1,50% | Actions |
| Walleye Capital LLC | $6 797 465 | 3 268 012 | 1,28% | Actions |
| RTW INVESTMENTS, LP | $6 760 000 | 3 250 000 | 1,28% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $6 397 849 | 3 075 889 | 1,21% | Actions |
| Ghisallo Capital Management LLC | $6 240 000 | 3 000 000 | 1,18% | Actions |
| Wildcat Capital Management, LLC | $6 075 237 | 2 920 787 | 1,15% | Actions |
| BANK OF AMERICA CORP /DE/ | $6 043 750 | 2 905 649 | 1,14% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 730 675 | 2 274 363 | 0,89% | Actions |
| DAFNA Capital Management LLC | $4 160 000 | 2 000 000 | 0,78% | Actions |
| TWO SIGMA ADVISERS, LP | $3 959 574 | 2 890 200 | 0,75% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $3 823 756 | 1 838 344 | 0,72% | Actions |
| Boxer Capital Management, LLC | $3 120 000 | 1 500 000 | 0,59% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3 026 614 | 1 455 103 | 0,57% | Actions |
| Raiffeisen Bank International AG | $2 442 000 | 1 100 000 | 0,46% | Actions |
| Vida Ventures Advisors, LLC | $2 229 722 | 1 798 163 | 0,42% | Actions |
| BlackRock, Inc. | $2 142 876 | 1 030 229 | 0,40% | Actions |
| Man Group plc | $1 459 954 | 701 901 | 0,28% | Actions |
| RAYMOND JAMES FINANCIAL INC | $1 412 262 | 678 972 | 0,27% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1 138 153 | 547 189 | 0,21% | Actions |
| CITIGROUP INC | $1 038 914 | 499 478 | 0,20% | Actions |
| Voleon Capital Management LP | $1 010 092 | 485 621 | 0,19% | Actions |
| AMERIPRISE FINANCIAL INC | $977 182 | 469 799 | 0,18% | Actions |
| TD Asset Management Inc | $961 126 | 462 080 | 0,18% | Actions |
| MACKENZIE FINANCIAL CORP | $893 489 | 429 562 | 0,17% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $886 650 | 426 274 | 0,17% | Actions |
| Erste Asset Management GmbH | $846 708 | 381 400 | 0,16% | Actions |
| ALPS ADVISORS INC | $728 630 | 350 303 | 0,14% | Actions |
| Rafferty Asset Management, LLC | $702 073 | 337 535 | 0,13% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $666 114 | 320 247 | 0,13% | Actions |
| RHUMBLINE ADVISERS | $644 248 | 309 741 | 0,12% | Actions |
| Moloney Securities Asset Management, LLC | $637 360 | 514 000 | 0,12% | Actions |
| Harold Davidson & Associates Inc. | $585 566 | 281 522 | 0,11% | Actions |
| IEQ CAPITAL, LLC | $582 257 | 279 931 | 0,11% | Actions |
| Bank of New York Mellon Corp | $558 216 | 268 373 | 0,11% | Actions |
| HSBC HOLDINGS PLC | $557 157 | 259 747 | 0,11% | Actions |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $554 147 | 266 417 | 0,10% | Actions |
| ALLIANCEBERNSTEIN L.P. | $551 142 | 225 878 | 0,10% | Actions |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $520 000 | 250 000 | 0,10% | Actions |
| Squarepoint Ops LLC | $502 370 | 241 524 | 0,09% | Actions |
| UBS Group AG | $494 220 | 237 606 | 0,09% | Actions |
| BIT Capital GmbH | $478 400 | 230 000 | 0,09% | Actions |
| WELLS FARGO & COMPANY/MN | $462 342 | 222 280 | 0,09% | Actions |
| LPL Financial LLC | $458 994 | 220 670 | 0,09% | Actions |
| Vanguard Global Advisers, LLC | $447 585 | 215 185 | 0,08% | Actions |
| CAXTON ASSOCIATES LP | $439 589 | 206 380 | 0,08% | Actions |
| Quadrature Capital Ltd | $437 825 | 210 493 | 0,08% | Actions |
| AMERICAN CENTURY COMPANIES INC | $431 400 | 207 404 | 0,08% | Actions |
| Headlands Technologies LLC | $427 342 | 205 453 | 0,08% | Actions |
| BARCLAYS PLC | $383 836 | 184 536 | 0,07% | Actions |
| OpenArc Corporate Advisory, LLC | $362 457 | 174 258 | 0,07% | Actions |
| CWM, LLC | $359 063 | 147 157 | 0,07% | Actions |
| Virtus Investment Advisers, LLC | $358 195 | 172 209 | 0,07% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $354 432 | 170 400 | 0,07% | Option d'achat |
| PROFUND ADVISORS LLC | $352 972 | 169 698 | 0,07% | Actions |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | $336 122 | 161 597 | 0,06% | Actions |
| WINTON GROUP Ltd | $328 973 | 158 160 | 0,06% | Actions |
| MetLife Investment Management, LLC | $324 844 | 156 175 | 0,06% | Actions |
| Smartleaf Asset Management LLC | $306 080 | 137 874 | 0,06% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $305 000 | 146 779 | 0,06% | Actions |
| JPMORGAN CHASE & CO | $291 295 | 131 214 | 0,05% | Actions |
| MARSHALL WACE, LLP | $290 479 | 139 653 | 0,05% | Actions |
| CHOREO, LLC | $260 129 | 125 062 | 0,05% | Actions |
| ALGERT GLOBAL LLC | $254 634 | 122 420 | 0,05% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $254 234 | 122 228 | 0,05% | Actions |
| Quantbot Technologies LP | $243 221 | 116 933 | 0,05% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $240 240 | 115 500 | 0,05% | Actions |
| Graham Capital Management, L.P. | $237 992 | 114 419 | 0,04% | Actions |
| Invesco Ltd. | $215 130 | 103 428 | 0,04% | Actions |
| Engineers Gate Manager LP | $204 903 | 98 511 | 0,04% | Actions |
| BANK OF NOVA SCOTIA | $202 592 | 97 400 | 0,04% | Actions |
| Xcelsior Advisor Partners LLC | $199 661 | 95 991 | 0,04% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $194 773 | 93 641 | 0,04% | Actions |
| AXQ CAPITAL, LP | $173 091 | 83 217 | 0,03% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $171 392 | 82 400 | 0,03% | Option de vente |
| Mariner, LLC | $167 681 | 80 616 | 0,03% | Actions |
| CAPTRUST FINANCIAL ADVISORS | $164 730 | 79 197 | 0,03% | Actions |
| MORGAN STANLEY | $164 104 | 78 896 | 0,03% | Actions |
| Police & Firemen's Retirement System of New Jersey | $162 822 | 78 280 | 0,03% | Actions |
| D. E. Shaw & Co., Inc. | $157 196 | 75 575 | 0,03% | Actions |
| CITADEL ADVISORS LLC | $149 344 | 71 800 | 0,03% | Option d'achat |
Initiés de la société 16 initiés · 6 dirigeants · 8 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Zachary Roberts | President and CEO | 1 juillet 2026 A | — | 0 | 0 | $0 |
| David D Chang | President and CEO | 23 mars 2022 A | 2 289 652 | 0 | 0 | $0 |
| Eric Thomas Schmidt | Chief Financial Officer | 23 mars 2022 A | 337 904 | 0 | 0 | $0 |
| Rafael Amado | EVP of R&D and CMO | 21 juin 2022 S | 544 257 | 0 | 0 | $0 |
| Veer Bhavnagri | General Counsel | 23 mars 2022 A | 589 279 | 0 | 0 | $0 |
| Alison Moore | Chief Technical Officer | 23 mars 2022 A | 120 430 | 0 | 0 | $0 |
| Stephen Mayo | Administrateur | 18 juin 2026 A | — | 0 | 0 | $0 |
| Elizabeth A. Barrett | Administrateur | 18 juin 2026 A | — | 0 | 0 | $0 |
| Deborah M. Messemer | Administrateur | 18 juin 2026 A | 6 535 | 0 | 0 | $0 |
| Owen N. Witte | Administrateur | 18 juin 2026 A | 233 271 | 0 | 0 | $0 |
| Franz B Humer | Administrateur | 18 juin 2026 A | 191 892 | 0 | 0 | $0 |
| Joshua A Kazam | Administrateur | 18 juin 2026 A | 398 463 | 0 | 0 | $0 |
| Vicki L Sato | Administrateur | 18 juin 2026 A | 41 451 | 0 | 0 | $0 |
| Pfizer Inc. | Détenteur de 10% | 15 octobre 2018 C | 22 032 040 | 0 | 0 | $0 |
| Earl Martin Douglas | — | 2 février 2026 A | 564 948 | 0 | 1 | $-40 304 |
| Arie Belldegrun | — | 2 février 2026 A | 4 710 120 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 5 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Pfizer Inc. | 13 février 2026 | 9,00% | Amendement | — | SEC |
| Pfizer Inc. (“Pfizer”) ×3 dépôts | 25 octobre 2023 | — | Dépôt initial | — | SEC |
| TPG GP A, LLC, David Bonderman, James G. Coulter, Jon Winkelried | 18 janvier 2022 | — | Dépôt initial | — | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×4 dépôts | 10 août 2020 | — | Dépôt initial | — | SEC |
| Pfizer Inc. (“ Pfizer ”) | 22 octobre 2018 | — | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 30 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,04% | 182 788 NS | 30 avril 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,12% | 303 899 NS | 30 avril 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 496 849 SH | 8 août 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 18 782 SH | 8 août 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 588 201 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 231 043 SH | 8 août 2026 | Quotidien |
| IBB · iShares Trust | 0,04% | 1 864 100 SH | 8 août 2026 | Quotidien |
| IWN · iShares Trust | 0,03% | 2 455 219 SH | 8 août 2026 | Quotidien |
| BIB · ProShares Trust | 0,02% | 8 308 NS | 31 mai 2026 | N-PORT |
| SMLF · iShares Trust | 0,02% | 479 966 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 1 528 157 SH | 8 août 2026 | Quotidien |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,02% | 27 987 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,02% | 6 776 183 SH | 8 août 2026 | Quotidien |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 204 346 NS | 31 mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 876 401 NS | 30 avril 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 1 207 257 NS | 31 mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 3 222 860 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,01% | 776 881 SH | 8 août 2026 | Quotidien |
| ITWO · ProShares Trust | 0,01% | 7 333 NS | 31 mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 5 734 NS | 31 mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 5 798 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 146 NS | 31 mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4 797 NS | 31 mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 241 276 NS | 30 avril 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 356 653 SH | 8 août 2026 | Quotidien |
| DFUS · Dimensional ETF Trust | 0,00% | 63 774 NS | 30 avril 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 149 554 NS | 31 mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 25 280 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 8 666 591 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 22 307 SH | 8 août 2026 | Quotidien |